Cancel
Known information
- Previously worked at Genentech Early Research and Development
- Instrumental in leading several transformational initiatives to advance multiple therapeutic programs covering diverse mechanistic pathways for cancer, inflammatory, and autoimmune indications
- Led various disease area research strategies focusing on autoimmune and inflammatory diseases
- Authored over 41 scientific publications and holds 5 patents
- Obtained a BS from the University of Minnesota
- Earned a PhD in Immunology from the University of Toronto
- Completed postdoctoral studies in the lab of pioneering geneticist and molecular immunologist, Fred Alt, at HHMI/Harvard
About TRex Bio
TRex Bio is a biotechnology company that develops treatments for immune-mediated diseases using a human tissue-based platform combined with machine learning and high-throughput '-omics'.
Report inaccurate information
